NOT-HL-22-029: Notice of NHLBI Participation in NOT-OD-22-140 "Notice of Special Interest: Administrative Supplement for Research Efforts that Illuminate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence" (Admin Supp Clinical Trial Optional)

Notice of NHLBI Participation in NOT-OD-22-140 "Notice of Special Interest: Administrative Supplement for Research Efforts that Illuminate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence" (Admin Supp Clinical Trial Optional)

Notice Number:

NOT-HL-22-029

Key Dates

Release Date:

June 15, 2022

Related Announcements

NOT-OD-22-140 - Notice of Special Interest (NOSI): Administrative Supplement for Research Efforts that Illuminate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence (Admin Supp Clinical Trial Optional)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective immediately, in NOT-OD-22-140 "Notice of Special Interest (NOSI): Administrative Supplement for Research Efforts that Illuminate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence (Admin Supp Clinical Trial Optional)".

The following sections of NOT-OD-22-140 have been modified to highlight NHLBI's participation in this FOA:

Currently Reads:

Related Announcements

PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

Issued by

Office of Behavioral and Social Sciences Research (OBSSR)

National Institute on Aging (NIA)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institute on Minority Health and Health Disparities (NIMHD)

Modified to Read (changes shown in bold italics):

Related Announcements

PA-20-272- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

NOT-HL-22-029 - Notice of Special Interest (NOSI): Administrative Supplement for Research Efforts that Illuminate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence (Admin Supp Clinical Trial Optional)

Issued by

Office of Behavioral and Social Sciences Research (OBSSR)

National Institute on Aging (NIA)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institute on Minority Health and Health Disparities (NIMHD)

National Heart, Lung, and Blood Institute (NHLBI)

Inquiries

Please direct all inquiries regarding this Notice to:

Scientific/Research Contact

Laurie Friedman Donze, PhD
National Heart, Lung and Blood Institute (NHLBI)
Division of Cardiovascular Sciences
Telephone: 301-827-1408
Email: laurie.donze@nih.gov

Financial/Grants Management Contact

Shelia Ortiz
National Heart, Lung and Blood Institute (NHLBI)
Office of Grants Management
Telephone: 301-827-8046
Email: shelia.ortiz@nih.gov